The latest trading day saw McKesson (MCK) settling at $508, representing a -0.03% change from its previous close.

Today, Benzinga's options scanner identified 12 options transactions for McKesson. This is an unusual occurrence. The ...

The Zacks Medical - Dental Supplies industry in the Medical sector has shown a consolidating trend in 2024 amid a rise in ...

On that day, McKesson is projected to report earnings of $7.11 per share ... with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The ...

McKesson Corporation MCK is well-poised for growth in the coming quarters, courtesy of its strong Biologics business. The ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors ...

Repeat expansions in the FGF14 gene can cause late-onset cerebellar ataxia (SCA27B), however the defining features of pathogenic expansions remain uncertain. Here, the authors compare the sequence ...

McKesson boasts solid revenue and EPS growth, supported by AI integration. Click here to read what offers a compelling ...

Leerink Partners analyst Michael Cherny has reiterated their bullish stance on MCK stock, giving a Buy rating on September 10. Michael Cherny ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...